Silymarin improved diet-induced liver damage and insulin resistance by decreasing inflammation in mice
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Silymarin improved diet-induced liver damage and insulin resistance by decreasing inflammation in mice
Authors
Keywords
-
Journal
PHARMACEUTICAL BIOLOGY
Volume 54, Issue 12, Pages 2995-3000
Publisher
Informa UK Limited
Online
2016-07-08
DOI
10.1080/13880209.2016.1199042
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury
- (2015) Chote Luangchosiri et al. BMC Complementary and Alternative Medicine
- Low-grade inflammation, diet composition and health: current research evidence and its translation
- (2015) Anne M. Minihane et al. BRITISH JOURNAL OF NUTRITION
- Silymarin Suppresses Cellular Inflammation By Inducing Reparative Stress Signaling
- (2015) Erica S. Lovelace et al. JOURNAL OF NATURAL PRODUCTS
- Silymarin Inhibits Morphological Changes in LPS-Stimulated Macrophages by Blocking NF-κB Pathway
- (2015) Eun Jeong Kim et al. KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
- Free Radical-Scavenging, Anti-Inflammatory/Anti-Fibrotic and Hepatoprotective Actions of Taurine and Silymarin against CCl4 Induced Rat Liver Damage
- (2015) Ashraf M. Abdel-Moneim et al. PLoS One
- Silymarin ameliorates fructose induced insulin resistance syndrome by reducing de novo hepatic lipogenesis in the rat
- (2014) Prem Prakash et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Global estimates of diabetes prevalence for 2013 and projections for 2035
- (2013) L. Guariguata et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Silibinin ameliorates steatosis and insulin resistance during non-alcoholic fatty liver disease development partly through targeting IRS-1/PI3K/Akt pathway
- (2013) Yongxiang Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes
- (2013) Tony Jourdan et al. NATURE MEDICINE
- Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin
- (2012) M K Piya et al. JOURNAL OF ENDOCRINOLOGY
- A role for the NLRP3 inflammasome in metabolic diseases—did Warburg miss inflammation?
- (2012) Haitao Wen et al. NATURE IMMUNOLOGY
- Chemopreventive effects of silymarin against 1,2-dimethylhydrazine plus dextran sodium sulfate-induced inflammation-associated carcinogenicity and genotoxicity in the colon of gpt delta rats
- (2011) Naomi Toyoda-Hokaiwado et al. CARCINOGENESIS
- The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
- (2011) Bolormaa Vandanmagsar et al. NATURE MEDICINE
- Chemopreventive Effect of Silymarin on Liver Pathology in HBV X Protein Transgenic Mice
- (2008) Y.-F. Wu et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More